🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels

RecruitingNAAges 18 Years - 85 YearsAllCai gaojun, MD
NCT07410364 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Randomized controlled trial of adaptive design for the safety and efficacy of coronary angiography and percutaneous coronary intervention via distal transradial access using a 6-French Glidesheath Slender in patients with small vessels.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 85 years * Palpable pulses in both the distal radial artery and conventional radial artery * All patients signed informed consent forms prior to procedure Exclusion Criteria: * Ultrasound assessment of the distal radial artery diameter ≥2.0mm or \<1.0mm * Height ≥185.0cm * Patients with acute ST-segment elevation myocardial infarction, cardiogenic shock, or hemodynamic instability * Contraindications for puncture of the distal radial artery * Patients with Raynaud's syndrome * Patients with coagulation disorders or hematologic diseases * Patients currently enrolled in other clinical studies
💊

What it tests

  • Performing coronary angiography and percutaneous coronary intervention via the distal transradial access in patients with small vessels (DRA < 2.0 mm) using a 6-Fr Glidesheath Slender sheath.
  • Performing coronary interventional procedures via the distal radial artery in patients with small vessels ( DRA diameter < 2.0 mm ) using a 6-Fr Conventional sheath.
📍

Where

2 sites
Changzhou Wujin People's Hospital
Changzhou, China
Wujin Hospital Affiliated with Jiangsu University.
Changzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy